(Q38715322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

review article

1 reference

title

Metabolomics in amyotrophic lateral sclerosis: how far can it take us? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

6 March 2020

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Christian Andres

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

5

P Vourc'h

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

B Madji Hounoum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

F Patin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

P H Gordon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

P Corcia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

447-454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers in amyotrophic lateral sclerosis

6 March 2020

cites work

1 reference

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

21 January 2018

1 reference

Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.

21 January 2018

1 reference

Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS.

21 January 2018

1 reference

Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging

21 January 2018

1 reference

Innovation: Metabolomics: the apogee of the omics trilogy

21 January 2018

1 reference

Analytical approaches to metabolomics and applications to systems biology

21 January 2018

1 reference

Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives

21 January 2018

1 reference

The application of biomarkers in clinical trials for motor neuron disease

21 January 2018

1 reference

Metabolomic analysis and signatures in motor neuron disease

21 January 2018

1 reference

Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis

21 January 2018

1 reference

1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis

21 January 2018

1 reference

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis

21 January 2018

1 reference

Biochemical alterations associated with ALS.

21 January 2018

1 reference

Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.

21 January 2018

1 reference

21 January 2018

1 reference

ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.

21 January 2018

1 reference

Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease

21 January 2018

1 reference

Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis

21 January 2018

1 reference

Applying proteomics to the diagnosis and treatment of ALS and related diseases

21 January 2018

1 reference

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

21 January 2018

1 reference

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

21 January 2018

1 reference

Branched-chain amino acids induce neurotoxicity in rat cortical cultures

21 January 2018

1 reference

The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats

21 January 2018

1 reference

Amino acids as biomarkers in the SOD1(G93A) mouse model of ALS.

21 January 2018

1 reference

Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis.

21 January 2018

1 reference

PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.

21 January 2018

1 reference

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data

21 January 2018

1 reference

Neuroproteomics tools in clinical practice

21 January 2018

1 reference

Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?

21 January 2018

1 reference

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.

21 January 2018

1 reference

Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry

21 January 2018

1 reference

Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS

21 January 2018

1 reference

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12956

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26822316%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference